뒤로
Argent BioPharma Limited(RGTLF) 가격
RGTLF 주가 차트
RGTLF 수입
Argent BioPharma Limited
$0.04
0%
$0
종가: Feb 06, 16:00:00 GMT-5
$0.04
0%
$0
애프터마켓: Feb 06, 20:00:00 GMT-5
Earnings FAQ
RGTLF의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Argent BioPharma Limited RGTLF의 지난 분기 매출 실적은 어땠나요?
Argent BioPharma Limited의 매출 추정치는 얼마인가요?
Argent BioPharma Limited의 수익 품질 점수는 얼마인가요?
Argent BioPharma Limited는 언제 수익을 보고하나요?
Argent BioPharma Limited의 예상 수익은 얼마인가요?
Argent BioPharma Limited은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.0475
시가
$0.0475
일일 범위
$0.0475 - $0.0475
52주 범위
$0.0105 - $0.2092
거래량
--
평균 거래량
3.1K
EPS(TTM)
-0.22
배당수익률
--
시가총액
$4.0M
Argent BioPharma Limited란 무엇인가요?
Argent BioPharma Ltd. engages in the production of medical marijuana. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2006-12-21. The Company’s assets, CannEpil and CimetrA, target immune dysregulation in drug-resistant epilepsy and cytokine-driven inflammatory disorders, respectively. The Company’s proprietary delivery technologies enhance penetration across the blood-brain and alveolar-capillary barriers, supporting differentiated efficacy and composition-of-matter protection. The company focuses on urgent unmet needs in the central nervous system (CNS) and systemic inflammation. Its product pipeline includes CimetrA, CannEpil, CogniCann and others. CannEpil is a refractory epilepsy seizure control treatment. CogniCann is an investigational oral spray developed by the Company to help manage symptoms associated with dementia and Alzheimer’s disease. The firm has a patient base in Australia, the United Kingdom, Brazil, and Ireland.